Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Puppy Protection Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including H.R. 3112/S. 1538 - Better CARE for Animals Act of 2025 and H.R. 2253 - Puppy Protection Act of 2025.
Puppy Protection Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including animal testing and research, the Better CARE for Animals Act (H.R. 3112/S. 1538) and the Puppy Protection Act (H.R. 2253).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CONTRACEPTION ACCESS INITIATIVE via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · RA
Issues related to FDA review of over-the-counter-contraception.
OUTPOST BRANDS, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Source: Senate LDA
| HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) |
| 2 |
| 2026 |
| NORTH AMERICAN OLIVE OIL ASSOCIATION (FKA ALLIANCE FOR OLIVE OIL QLTY STNDRDS) | 2 | 2026 |
| ORNUA FOODS NORTH AMERICA, INC. | 2 | 2026 |
| PIEDMONT HEALTHCARE INC. | 2 | 2026 |
| PRN SOFTWARE, LLC | 2 | 2026 |
| SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) | 2 | 2026 |
| CELLDEX THERAPEUTICS, INC. | 1 | 2026 |
| FUJIFILM HOLDINGS AMERICA CORPORATION | 1 | 2026 |
Better CARE for Animals Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including H.R. 3112/S. 1538 - Better CARE for Animals Act of 2025 and H.R. 2253 - Puppy Protection Act of 2025.
Better CARE for Animals Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including animal testing and research, the Better CARE for Animals Act (H.R. 3112/S. 1538) and the Puppy Protection Act (H.R. 2253).
Issues related to behavioral health services, prescription drug monitoring programs, care coordination, including for VA, Medicare and Medicaid beneficiaries, and veteran mental health; Issues related to the 988 Suicide and Crisis Lifeline; Issues related to the Great American Recovery Initiative; Issues related to the final FY26 Labor-HHS Appropriations bill (P.L. 119-75); Issues related to SUPPORT Act reauthorization (including S. 2433, H.R. 4531); Issues related to the RECONNECTIONS Act (within H.R.4531/S. 2433); Issues related to FY27 appropriations and related report language for Labor-HHS and CJS, including Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260) and Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 (H.R. 8845).
Health Tech Investment Act
Client: SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to cancer care, treatment, screening, and artificial intelligence use in health care including H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to cybersecurity.
Health Tech Investment Act
Client: SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to cancer care, treatment, screening, and artificial intelligence use in health care including H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to cybersecurity.
Issues related to FDA regulatory legislation, including H.R. 8000 - END 7-OH Act; Issues related to FDA and DEA regulatory action on 7-OH.
Issues related to FDA regulatory legislation, including H.R. 8000 - END 7-OH Act; Issues related to FDA and DEA regulatory action, including on 7-OH
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: BIOSPLICE THERAPEUTICS, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; Issues related to H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
Client: BIOSPLICE THERAPEUTICS, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260).
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination, including for VA, Medicare and Medicaid beneficiaries, and veteran mental health; Issues related to the 988 Suicide and Crisis Lifeline; Issues related to the Great American Recovery Initiative; Issues related to the final FY26 Labor-HHS Appropriations bill (P.L. 119-75); Issues related to SUPPORT Act reauthorization (including S. 2433, H.R. 4531); Issues related to the RECONNECTIONS Act (within H.R.4531/S. 2433); Issues related to FY27 appropriations and related report language for Labor-HHS and CJS, including Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260) and Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 (H.R. 8845).
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75); Issues related to the SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues related to H.R.8845 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BIOSPLICE THERAPEUTICS, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; Issues related to H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BIOSPLICE THERAPEUTICS, INC. · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination, including for VA, Medicare and Medicaid beneficiaries, and veteran mental health; Issues related to the 988 Suicide and Crisis Lifeline; Issues related to the Great American Recovery Initiative; Issues related to the final FY26 Labor-HHS Appropriations bill (P.L. 119-75); Issues related to SUPPORT Act reauthorization (including S. 2433, H.R. 4531); Issues related to the RECONNECTIONS Act (within H.R.4531/S. 2433); Issues related to FY27 appropriations and related report language for Labor-HHS and CJS, including Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260) and Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 (H.R. 8845).
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75); Issues related to the SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues related to H.R.8845 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027.
Health Tech Investment Act
Client: SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to cancer care, treatment, screening, and artificial intelligence use in health care including H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to cybersecurity.
Health Tech Investment Act
Client: SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to cancer care, treatment, screening, and artificial intelligence use in health care including H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to cybersecurity.
Better CARE for Animals Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including H.R. 3112/S. 1538 - Better CARE for Animals Act of 2025 and H.R. 2253 - Puppy Protection Act of 2025.
Better CARE for Animals Act of 2025
Client: HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to animal welfare, including animal testing and research, the Better CARE for Animals Act (H.R. 3112/S. 1538) and the Puppy Protection Act (H.R. 2253).
Neonatal Care Transparency Act of 2025
Client: BAMBOO HEALTH · Firm: AKIN GUMP STRAUSS HAUER & FELD
Issues related to behavioral health services, prescription drug monitoring programs, care coordination, including for VA, Medicare and Medicaid beneficiaries, and veteran mental health; Issues related to the 988 Suicide and Crisis Lifeline; Issues related to the Great American Recovery Initiative; Issues related to the final FY26 Labor-HHS Appropriations bill (P.L. 119-75); Issues related to SUPPORT Act reauthorization (including S. 2433, H.R. 4531); Issues related to the RECONNECTIONS Act (within H.R.4531/S. 2433); Issues related to FY27 appropriations and related report language for Labor-HHS and CJS, including Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260) and Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 (H.R. 8845).
Issues related to FDA regulatory legislation, including H.R. 8000 - END 7-OH Act; Issues related to FDA and DEA regulatory action, including on 7-OH
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
HEALTHCARE DISTRIBUTION ALLIANCE via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to distributor-supported service models and related policy, including pharmacy services administrative organizations and management services organizations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORNUA FOODS NORTH AMERICA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to nutrition policy.
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office
HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to animal welfare, including animal testing and research, the Better CARE for Animals Act (H.R. 3112/S. 1538) and the Puppy Protection Act (H.R. 2253).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to cancer care, treatment, screening, and artificial intelligence use in health care including H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to cybersecurity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PIEDMONT HEALTHCARE INC via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues pertaining to hospital reimbursement rates.
Issues related to the Enhanced Premium Tax Credits; Issues related to hospital reimbursement rates.
Filing targets: HOUSE OF REPRESENTATIVES
NORTH AMERICAN OLIVE OIL ASSOCIATION (FKA ALLIANCE FOR OLIVE OIL QLTY STNDRDS) via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to the standard of identity for olive oil.
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
INTERNATIONAL FLAVORS & FRAGRANCES via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to food ingredients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRN SOFTWARE, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to prescription drug price transparency and real-time benefit tool.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOSPLICE THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; related FY27 appropriations report language, including Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 (H.R. 8646) and Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260).
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · Q3
Issues related to behavioral health services, prescription drug monitoring programs, care coordination, including for VA, Medicare and Medicaid beneficiaries, and veteran mental health; Issues related to the 988 Suicide and Crisis Lifeline; Issues related to the Great American Recovery Initiative; Issues related to the final FY26 Labor-HHS Appropriations bill (P.L. 119-75); Issues related to SUPPORT Act reauthorization (including S. 2433, H.R. 4531); Issues related to the RECONNECTIONS Act (within H.R.4531/S. 2433); Issues related to FY27 appropriations and related report language for Labor-HHS and CJS, including Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260) and Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 (H.R. 8845).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONTRACEPTION ACCESS INITIATIVE via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · RR
Issues related to FDA review of over-the-counter contraception.
HEALTHCARE DISTRIBUTION ALLIANCE via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · RR
Issues related to distributor-supported service models and related policy.
PRN SOFTWARE, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · third_quarter · RR
Issues related to information blocking and transparency.
INTERNATIONAL FLAVORS & FRAGRANCES via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to food ingredients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORNUA FOODS NORTH AMERICA, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to nutrition policy.
Issues related to trade tariffs.
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Trade Representative (USTR), White House Office
PIEDMONT HEALTHCARE INC via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to enhanced premium tax credits.
Filing targets: HOUSE OF REPRESENTATIVES
FUJIFILM HOLDINGS AMERICA CORPORATION via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to biopharmaceutical manufacturing in the United States.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CELLDEX THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to mast cell conditions and therapies; Issues related to drug development and biopharma ecosystem.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOSPLICE THERAPEUTICS, INC. via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to the development of therapies for osteoarthritis and areas of significant unmet medical need; Issues related to H.R.8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027; Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
BAMBOO HEALTH via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; Issues related to 988 Suicide and Crisis Lifeline; Issues related to the Consolidated Appropriations Act, 2026 (P.L. 119-75); Issues related to the SUPPORT for Patients and Communities Reauthorization Act of 2025 (P.L. 119-44); Issues related to H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues related to H.R.8845 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SIEMENS HEALTHINEERS (FKA VARIAN MEDICAL SYSTEMS, INC.) via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to cancer care, treatment, screening, and artificial intelligence use in health care including H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to cybersecurity.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
OUTPOST BRANDS, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to FDA regulatory legislation, including H.R. 8000 - END 7-OH Act; Issues related to FDA and DEA regulatory action on 7-OH.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
NORTH AMERICAN OLIVE OIL ASSOCIATION (FKA ALLIANCE FOR OLIVE OIL QLTY STNDRDS) via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to federal regulation and policies regarding olive oil.
Issues related to the standard of identity for olive oil.
Filing targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
HUMANE WORLD ACTION FUND (FKA HUMANE SOCIETY LEGISLATIVE FUND) via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · Q2
Issues related to animal welfare, including H.R. 3112/S. 1538 - Better CARE for Animals Act of 2025 and H.R. 2253 - Puppy Protection Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OUTPOST BRANDS, LLC via AKIN GUMP STRAUSS HAUER & FELD
2026 · second_quarter · RR
Issues related to FDA regulation of kratom 7-hydroxy (7-OH).
INTERNATIONAL FLAVORS & FRAGRANCES via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · Q1
Issues related to food ingredients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL FLAVORS & FRAGRANCES via AKIN GUMP STRAUSS HAUER & FELD
2026 · first_quarter · RR
Issues related to trade and tariffs; Issues related to food ingredient safety reform.
Issues related to trade and tariffs; Issues related to food ingredient safety reform.